Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Megan Barnden"'
Autor:
Milica Ng, Steve Rockman, Dorit Becher, Allison Dyson, Eugene Maraskovsky, Megan Barnden, Adriana Baz Morelli, Sandra Koernig, Mimi L.K. Tang, Martin J. Pearse
Publikováno v:
Vaccine. 32(30):3861-3868
In Australia, during the 2010 Southern Hemisphere (SH) influenza season, there was an unexpected increase in post-marketing adverse event reports of febrile seizures (FS) in children under 5 years of age shortly after vaccination with the CSL trivale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8aaf111c8d8474506221e0a424d16e2
Autor:
Megan Barnden, Richard J. Hillman, Charmaine Gittleson, Jennifer F Hoy, Jonathan Anderson, Beng Eu, Andrew McKenzie
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 52:371-381
Objective Study aimed to assess safety, tolerability, and immunogenicity of novel therapeutic HPV-16 E6E7 ISCOMATRIX vaccine for treatment of human papilloma virus (HPV)-related anal intraepithelial neoplasia in HIV-infected men who have sex with men
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0601b5b14306c359432adb77f93aef98
https://doi.org/10.1097/qai.0b013e3181b7354c
https://doi.org/10.1097/qai.0b013e3181b7354c
Autor:
Debbie Drane, Megan Barnden, Eugene Maraskovsky, Gervase Barbara A, Rebecca Gibson, Stephen R. Coates, Russell L. Basser, Sue Mitchell, David Shaw, Alan Moskwa, Michael Houghton
Publikováno v:
Human Vaccines. 5:151-157
The disease burden and public health impact of chronic HCV infection continues to be a major problem globally. Current treatment for chronic HCV infection is not effective in all patients and is frequently associated with unacceptable side effects. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce373f3daa29b9fde9ffc363d93a2b73
https://doi.org/10.4161/hv.5.3.6614
https://doi.org/10.4161/hv.5.3.6614
Autor:
Paula Marlton, Samantha J. Busfield, Simon He, Simon Durrant, Hayley S. Ramshaw, Megan Barnden, Angel F. Lopez, Ian D. Lewis, Trina Yeadon, Andrew W. Roberts, Russell L. Basser, Mark DeWitte, Andrew J. McLachlan, Ian Kerridge, David Ritchie, Harry J. Iland, Mark Hertzberg, Glen A Kennedy, Simone Bamford, Andrew W. Boyd, Kenneth F. Bradstock
Acute myeloid leukemia (AML) blasts express high levels of interlekin-3 (IL-3) receptor-α (CD123). CSL360 is a recombinant, chimeric immunoglobulin G1 (IgG1), anti-CD123 monoclonal antibody (MoAb) that neutralizes IL-3 and demonstrates anti-leukemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53153ed41770ebbcd421422583e74c33
https://hdl.handle.net/11541.2/119929
https://hdl.handle.net/11541.2/119929
Autor:
Steve Rockman, Sarina Camuglia, Martin J. Pearse, Dorit Becher, Sandra Koernig, Allison Dyson, Megan Barnden, Peter Soupourmas, Adriana Baz Morelli, Eugene Maraskovsky
Publikováno v:
Vaccine. 32(30)
In Australia, during the 2010 Southern Hemisphere (SH) influenza season, there was an unexpected increase in post-marketing adverse event reports of febrile seizures (FS) in children under 5 years of age shortly after vaccination with the CSL 2010 SH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a91298bb4536d819153f014eecae0de
https://pubmed.ncbi.nlm.nih.gov/24681272
https://pubmed.ncbi.nlm.nih.gov/24681272
Autor:
Sarina Camuglia, Razvan Cristescu, Steve Rockman, Martin J. Pearse, Adriana Baz Morelli, Kirsten Vandenberg, Allison Dyson, Jesse Bodle, Mike Citron, Dorit Becher, Jane Fontenot, Sandra Koernig, Eugene Maraskovsky, I-Ming Wang, Peter Schoofs, Megan Barnden, Andrey Loboda, Derchieh Hung
Publikováno v:
Vaccine. 30(51)
During the 2010 Southern Hemisphere (SH) influenza season, there was an unexpected increase in the number of febrile reactions reported in the paediatric population in Australia shortly after vaccination with the CSL 2010 trivalent influenza vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8147fc6b6e384d1e37d35746c9f648
https://pubmed.ncbi.nlm.nih.gov/23632308
https://pubmed.ncbi.nlm.nih.gov/23632308
Autor:
Samantha J. Busfield, Gail J. Roboz, Tania J. Curcio, Jessica K. Altman, Sue Dasen, Megan Barnden, B. Douglas Smith, Roslyn Davis, Kaysey F. Orlowski, Mark DeWitte, Andrew W. Roberts, Anna Ferguson, Roland B. Walter, Sarah Hosback, Souravi Ghosh, Debra M. Bensen-Kennedy, Linda Garrett, Allison Dyson, Brad Sedgmen
Publikováno v:
Blood. 124:120-120
Background: Most patients with acute myeloid leukemia (AML) die from relapsed disease, including those who attain complete remission (CR). Post-remission treatment designed to kill chemoresistant leukemia stem cells (LSC) and eradicate minimal residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44e2b63f28fc02861cb7cdb91b9c40f2
https://doi.org/10.1182/blood.v124.21.120.120
https://doi.org/10.1182/blood.v124.21.120.120
Autor:
Russell L. Basser, Kenneth F. Bradstock, Simon Durrant, Danijela Mirosa, Trina Yeadon, Megan Barnden, Sarah Hosback, Mark DeWitte, Mark Biondo, Simon He, David Ritchie, Roslyn Davis, Mark Hertzberg, Samantha J. Busfield, Andrew J. McLachlan, Ian D. Lewis, Paula Marlton, Andrew W. Roberts, Simone Bamford
Publikováno v:
Blood. 112:2956-2956
CD123 (IL-3Rα) is a phenotypic marker of putative leukemic stem cells (LSC) in AML (Jordan, Leukemia2000;14:1777). We and others have found that CD34+38− cells from AML patients (pts) express high levels of CD123, in contrast to absence of express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7d216e106d137dc72d826d45387b2ff
https://doi.org/10.1182/blood.v112.11.2956.2956
https://doi.org/10.1182/blood.v112.11.2956.2956